Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Go back to Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 20.03 +0.12 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.91 | 52 Week High | $0.19 | |||
| Open | $20.04 | 52 Week Low | $0.07 | |||
| Day High | $20.28 | P/E | N/A | |||
| Day Low | $19.86 | EPS | $-0.01 | |||
| Volume | 4,587,319 | |||||
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 20.03 +0.12 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.91 | 52 Week High | $0.19 | |||
| Open | $20.04 | 52 Week Low | $0.07 | |||
| Day High | $20.28 | P/E | N/A | |||
| Day Low | $19.86 | EPS | $-0.01 | |||
| Volume | 4,587,319 | |||||



